首页> 外文期刊>Polish Archives of Internal Medicine >Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease
【24h】

Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease

机译:哮喘和慢性阻塞性肺疾病患者不同呼吸样本骨膜蛋白表达的比较研究

获取原文
           

摘要

INTRODUCTION Periostin is considered to be a marker of eosinophilic inflammation in patients with asthma. However, there are no literature data on periostin in patients with chronic obstructive pulmonary disease (COPD). OBJECTIVES The aim of the study was to evaluate periostin expression and to compare its concentrations in various materials in patients with mild-to-moderate asthma and COPD, as well as to evaluate the potential association between periostin and clinical features of both diseases. PATIENTS AND METHODS Using an enzyme-linked immunosorbent assay, we measured periostin concentrations?in serum, induced sputum (IS), exhaled breath condensate (EBC), and bronchoalveolar lavage fluid (BALF) as?well as periostin expression in bronchial biopsy samples in 24 patients with asthma, 36 patients with COPD,?and 12 controls. Correlations between periostin levels in different materials were also analyzed and periostin?concentrations were compared between patients with asthma and those with COPD. RESULTS Periostin levels were detectable in serum, IS, EBC, and BALF from patients with asthma, COPD, and controls. EBC periostin levels correlated with tissue periostin expression and were significantly higher in asthma than in COPD (P = 0.04). Periostin expression in bronchial mucosa was higher in asthma than in COPD (P <0.001), as well as in asthma and COPD patients compared with controls (P <0.001). No significant correlations between tissue periostin expression and BALF, IS, or serum periostin levels were found. There were no differences in serum, IS, BALF, or EBC periostin concentrations between patients with different phenotypes of both diseases. CONCLUSIONS Periostin may be detected not only in serum, IS, and airway tissue samples, but also in EBC and BALF. EBC periostin levels and tissue periostin expression are higher in patients with asthma than in those with COPD. EBC periostin levels may serve as a potential surrogate marker for tissue periostin expression.
机译:引言Periostin被认为是哮喘患者嗜酸性粒细胞炎症的标志。然而,目前尚无关于慢性阻塞性肺疾病(COPD)患者骨膜素的文献资料。目的该研究的目的是评估骨膜蛋白的表达,并比较轻度至中度哮喘和COPD患者各种物质中骨膜蛋白的浓度,以及评估骨膜蛋白与两种疾病的临床特征之间的潜在关联。病人和方法使用酶联免疫吸附法,我们测量了血清,诱导痰(IS),呼出气冷凝物(EBC)和支气管肺泡灌洗液(BALF)中骨膜素的浓度以及支气管活检样本中骨膜素的表达。哮喘24例,慢性阻塞性肺病36例,对照组12例。还分析了不同材料中骨膜素水平之间的相关性,并比较了哮喘患者和COPD患者的骨膜素浓度。结果在患有哮喘,COPD和对照的患者的血清,IS,EBC和BALF中可检测到骨膜素水平。 EBC骨膜素水平与组织骨膜素表达相关,哮喘患者中EBC骨膜素水平显着高于COPD(P = 0.04)。与对照组相比,哮喘患者支气管粘膜中骨膜素的表达高于COPD(P <0.001),哮喘患者和COPD患者的血浆Periostin表达也高于对照组(P <0.001)。在组织骨膜蛋白表达与BALF,IS或血清骨膜蛋白水平之间未发现显着相关性。在两种疾病的表型不同的患者之间,血清,IS,BALF或EBC骨膜素浓度没有差异。结论不仅可以在血清,IS和气道组织样本中检测到骨膜素,而且在EBC和BALF中也可以检测到骨膜素。哮喘患者的EBC骨膜素水平和组织骨膜素表达高于COPD患者。 EBC骨膜素水平可作为组织骨膜素表达的潜在替代指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号